Before, Satoh et al. assessed survivin occurrence in pancreatic carcinoma cell lines and various pancreatic tissue types by immunohistochemistry, immunoblotting, and reverse transcription-polymerase chain reaction (RT-PCR) to examine the interrelation of survivin expression with tumour apoptosis and tumourigenesis. The gene discussed is BIRC5; the disease is exocrine pancreatic carcinoma.